Recruitment of HIF-1α and HIF-2α to common target genes is differentially regulated in neuroblastoma:: HIF-2α promotes an aggressive phenotype

被引:598
作者
Holmquist-Mengelbier, Linda
Fredlund, Erik
Lofstedt, Tobias
Noguera, Rosa
Navarro, Samuel
Nilsson, Helen
Pietras, Alexander
Vallon-Christersson, Johan
Borg, Ake
Gradin, Katarina
Poellinger, Lorenz
Pahlman, Sven [1 ]
机构
[1] Lund Univ, Univ Hosp MAS, Dept Lab Med, Div Mol Med, SE-20502 Malmo, Sweden
[2] Univ Valencia, Sch Med, Dept Pathol, Valencia 46010, Spain
[3] Lund Univ, Dept Oncol, SE-22100 Lund, Sweden
[4] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden
关键词
D O I
10.1016/j.ccr.2006.08.026
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In neuroblastoma specimens, HIF-2 alpha but not HIF-1 alpha is strongly expressed in well-vascularized areas. In vitro, HIF-2 alpha protein was stabilized at 5% O-2 (resembling end capillary oxygen conditions) and, in contrast to the low HIF-1a activity at this oxygen level, actively transcribed genes like VEGF. Under hypoxia (1% O-2), HIF-1 alpha was transiently stabilized and primarily mediated acute responses, whereas HIF-2 alpha protein gradually accumulated and governed prolonged hypoxic gene activation. Knockdown of HIF-2 alpha reduced growth of neuroblastoma tumors in athymic mice. Furthermore, high HIF-2 alpha protein levels were correlated with advanced clinical stage and high VEGF expression and predicted poor prognosis in a clinical neuroblastoma material. Our results demonstrate the relevance of HIF-2 alpha in neuroblastorna progression and have general tumor biological implications.
引用
收藏
页码:413 / 423
页数:11
相关论文
共 57 条
[1]   Genetic evidence for a tumor suppressor role of HIF-2α [J].
Acker, T ;
Diez-Juan, A ;
Aragones, J ;
Tjwa, M ;
Brusselmans, K ;
Moons, L ;
Fukumura, D ;
Moreno-Murciano, MP ;
Herbert, JM ;
Burger, A ;
Riedel, J ;
Elverl, G ;
Flamme, I ;
Maxwell, PH ;
Collen, D ;
Dewerchin, M ;
Jain, RK ;
Plate, KH ;
Carmeliet, P .
CANCER CELL, 2005, 8 (02) :131-141
[2]   Developmental expression of HERV-R (ERV3) and HERV-K in human tissue [J].
Andersson, AC ;
Venables, PJW ;
Tönjes, RR ;
Scherer, J ;
Eriksson, L ;
Larsson, E .
VIROLOGY, 2002, 297 (02) :220-225
[3]  
Blancher C, 2000, CANCER RES, V60, P7106
[4]   Exploiting tumour hypoxia in cancer treatment [J].
Brown, JM ;
William, WR .
NATURE REVIEWS CANCER, 2004, 4 (06) :437-447
[5]   Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers -: art. no. 27 [J].
Cangul, H .
BMC GENETICS, 2004, 5 (1)
[6]   VEGF as a key mediator of angiogenesis in cancer [J].
Carmeliet, P .
ONCOLOGY, 2005, 69 :4-10
[7]   The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers [J].
Chakrabarti, J ;
Turley, H ;
Campo, L ;
Han, C ;
Harris, AL ;
Gatter, KC ;
Fox, SB .
BRITISH JOURNAL OF CANCER, 2004, 91 (05) :954-958
[8]   HIF-2α regulates Oct-4:: effects of hypoxia on stem cell function, embryonic development, and tumor growth [J].
Covello, KL ;
Kehler, J ;
Yu, HW ;
Gordan, JD ;
Arsham, AM ;
Hu, CJ ;
Labosky, PA ;
Simon, MC ;
Keith, B .
GENES & DEVELOPMENT, 2006, 20 (05) :557-570
[9]   Targeted replacement of hypoxia-inducible factor-1α by a hypoxia-inducible factor-2α knock-in allele promotes tumor growth [J].
Covello, KL ;
Simon, MC ;
Keith, B .
CANCER RESEARCH, 2005, 65 (06) :2277-2286
[10]   The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-α [J].
Dayan, F ;
Roux, D ;
Brahimi-Horn, MC ;
Pouyssegur, J ;
Mazure, NM .
CANCER RESEARCH, 2006, 66 (07) :3688-3698